Abstract
Background and ObjectivesPredictive factors for rituximab (RTX) response in rheumatoid arthritis (RA) patients are currently still under debate. Repeated re-treatment is now the rule, but it is worth knowing if...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
